Dynamic Healthcare M&A Database

Acquiring Party	Greatbatch, Inc. (NYSE:GB), a manufacturer of critical components used in implantable medical devices.
Transferring Party	Precimed, Inc., a maker of instrumentation for hip & knee replacement, trauma and spine, sold worldwide to leading orthopedic OEM customers.
Sector	Medical Devices
Date	November 27, 2007
Analysis Establishes Greatbatch as a leading supplier of orthorpedic OEM component products (implantables) and diversifies its market focus, extending to cardiac rhythm management, vascular, and neurostimulation, in addition to orthopedic. With operations in several U.S. and international locations. Precimed makes innovative products in growing market segments such as minimally invasive surgery, resurfacing, and computer-aided surgery. The orthopedic market is seen as a $20b industry growing at approximately 10% annually. Deal value -- $125m, plus up to $10m earnout based on 08 revenues. This is the fouth medical acquisition for Greatbatch in 07.
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason.

Dynamic Healthcare M&A Database - 4Q07